Ogren Plant Allergy Scale

From WikiMD's WELLNESSPEDIA

The Ogren Plant Allergy Scale (OPALS) is a numerical scale that measures the potential of plants to cause allergic reactions. Developed by Thomas Leo Ogren, the scale ranges from 1 to 10, with higher numbers indicating a greater likelihood of causing allergies. The scale is used by landscapers, urban planners, and individuals to select plants that are less likely to trigger allergic reactions, thereby promoting healthier environments.

Development[edit]

The OPALS was created by Thomas Leo Ogren, a horticulturist and allergy researcher, in response to the increasing prevalence of allergies and asthma. Ogren's research focused on the role of urban landscaping in exacerbating these conditions. He identified that certain plants, particularly male cultivars that produce large amounts of pollen, were significant contributors to airborne allergens.

Scale Criteria[edit]

The OPALS takes into account several factors to determine a plant's allergy potential:

  • Pollen production
  • Pollen potency
  • Pollen size
  • Pollen season length
  • Plant sex (male plants typically produce more pollen)
  • Plant toxicity
  • Plant fragrance
  • Plant sap

Each plant is evaluated based on these criteria and assigned a score from 1 to 10. Plants with scores of 1-3 are considered low-allergy, 4-6 moderate-allergy, and 7-10 high-allergy.

Applications[edit]

The OPALS is used in various fields to minimize the impact of plant allergens:

  • Urban planning: To design allergy-friendly public spaces.
  • Landscaping: To select plants for residential and commercial properties.
  • Public health: To reduce the incidence of allergy-related health issues.

Benefits[edit]

Using the OPALS can lead to several benefits:

  • Reduced incidence of allergic rhinitis and asthma.
  • Improved quality of life for individuals with allergies.
  • Enhanced public health outcomes.

Related Pages[edit]

See Also[edit]

References[edit]


External Links[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.